93
Views
1
CrossRef citations to date
0
Altmetric
Review

Middle East Respiratory Syndrome – What Every Otolaryngologist Should Know: A Review

ORCID Icon
Pages 483-489 | Published online: 30 Jul 2020

References

  • Al Awaidy S, Al Hashami H. Zoonotic diseases in Oman: successes, challenges, and future directions. Vector Borne Zoonotic Dis. 2020;20(1):1–9. doi:10.1089/vbz.2019.245831486732
  • European Centre for Disease Prevention and Control. Epidemiological update: Middle East respiratory syndrome coronavirus (MERS-CoV). Available from: https://www.ecdc.europa.eu/en/news-events/epidemiological-update-middle-east-respiratory-syndrome-coronavirus-mers-cov-2. Accessed July 27, 2020.
  • Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–192. doi:10.1038/s41579-018-0118-930531947
  • Al Mutair A, Ambani Z. Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: updates and implications for practice. J Int Med Res. 2020;48(1):300060519858030. doi:10.1177/030006051985803031256729
  • Corman VM, Lienau J, Witzenrath M. Coronaviruses as the cause of respiratory infections. Internist (Berl). 2019;60(11):1136–1145. doi:10.1007/s00108-019-00671-531455974
  • Hakawi A, Rose EB, Biggs HM, et al. Middle East respiratory syndrome coronavirus, Saudi Arabia, 2017–2018. Emerg Infect Dis. 2019;25(11):2149–2151. doi:10.3201/eid2511.19072631430248
  • Hemida MG. Middle East respiratory syndrome coronavirus and the one health concept. PeerJ. 2019;7:e7556. doi:10.7717/peerj.755631497405
  • Kandeil A, Gomaa M, Nageh A, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Africa and Middle East. Viruses. 2019;11(8):717. doi:10.3390/v11080717
  • Kivisto I, Tidenberg E-M, Lilley T, et al. First report of coronaviruses in Northern European bats. Vector Borne Zoonotic Dis. 2020;20(2):155–158. doi:10.1089/vbz.2018.236731503522
  • Lee JY, Bae S, Myoung J. Middle East respiratory syndrome coronavirus-encoded accessory proteins impair MDA5-and TBK1-mediated activation of NF-κB. J Microbiol Biotechnol. 2019;29(8):1316–1323. doi:10.4014/jmb.1908.0800431434175
  • Li F, Du L. MERS coronavirus: an emerging zoonotic virus. Viruses. 2019;11(7):663. doi:10.3390/v11070663
  • Abdirizak F, Lewis R, Chowell G. Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting. Theor Biol Med Model. 2019;16(1):16. doi:10.1186/s12976-019-0112-631587665
  • Adhikari U, Chabrelie A, Weir M, et al. A case study evaluating the risk of infection from Middle Eastern respiratory syndrome coronavirus (MERS-CoV) in a hospital setting through bioaerosols. Risk Anal. 2019;39(12):2608–2624. doi:10.1111/risa.1338931524301
  • Agostini ML, Pruijssers AJ, Chappell JD, et al. Small molecule antiviral β-D-N(4)-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance. J Virol2019;93(24):e1348–19. doi:10.1128/JVI.01348-19
  • Alagaili AN, Briese T, Amor NMS, Mohammed OB, Lipkin WI. Waterpipe smoking as a public health risk: potential risk for transmission of MERS-CoV. Saudi J Biol Sci. 2019;26(5):938–941. doi:10.1016/j.sjbs.2018.05.00631303822
  • Blackman MA, Marchionni MA, Gilly J, et al. Summit proceedings: biomedical countermeasure development for emerging vector-borne viral diseases. Vaccine. 2019;37(43):6248–6254. doi:10.1016/j.vaccine.2019.08.06131500964
  • Jo S, Kim H, Kim S, Shin DH, Kim M-S. Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem Biol Drug Des. 2019;94(6):2023–2030. doi:10.1111/cbdd.1360431436895
  • Kato H, Takayama-Ito M, Iizuka-Shiota I, et al. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice. PLoS One. 2019;14(10):e0223684. doi:10.1371/journal.pone.022368431589656
  • Meyerholz DK, Lambertz AM, McCray PB Jr. Dipeptidyl peptidase 4 distribution in the human respiratory tract. Am J Pathol. 2016;186(1):78–86. doi:10.1016/j.ajpath.2015.09.01426597880
  • Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38(1):1–9. doi:10.12932/AP-200220-077232105090
  • de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523–534. doi:10.1038/nrmicro.2016.8127344959
  • Lu L, Manopo I, Leung BP, et al. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol. 2004;42(4):1570–1576. doi:10.1128/JCM.42.4.1570-1576.200415071006
  • Buchholz UJ, Bukreyev A, Yang L, et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci U S A. 2004;101(26):9804–9809. doi:10.1073/pnas.040349210115210961
  • Peng H, Yang L, Wang L, et al. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology. 2006;351(2):466–475. doi:10.1016/j.virol.2006.03.03616690096
  • Leung DT, Tam FC, Ma CH, et al. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis. 2004;190(2):379–386. doi:10.1086/42204015216476
  • Watson JG, Bird AG, editors. Chapter 1 - basic immunology In: Handbook of Immunological Investigations in Children. Oxford: Butterworth-Heinemann; 1990.
  • Tirado SM, Yoon KJ. Antibody-dependent enhancement of virus infection and disease. Viral Immunol. 2003;16(1):69–86. doi:10.1089/08828240376363546512725690
  • Van Kerkhove MD, Alaswad S, Assiri A, et al. Transmissibility of MERS-CoV infection in closed setting, Riyadh, Saudi Arabia, 2015. Emerg Infect Dis. 2019;25(10):1802–1809. doi:10.3201/eid2510.19013031423971
  • Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv Virus Res. 2019;105:93–116.31522710
  • Maier HJ, Bickerton E, Britton P, eds. Coronaviruses: Methods in Molecular Biology. New York, NY: Humana Press; 2015.
  • Woo CY, Lau KP, Lam SF, et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol. 2012;86(7):3995–4008. doi:10.1128/JVI.06540-1122278237
  • Tamin A, Queen K, Paden CR, et al. Isolation and growth characterization of novel full length and deletion mutant human MERS-CoV strains from clinical specimens collected during 2015. J Gen Virol. 2019;100(11):1523–1529. doi:10.1099/jgv.0.00133431592752
  • Sikkema RS, Farag EABA, Islam M, et al. Global status of Middle East respiratory syndrome coronavirus in dromedary camels: a systematic review. Epidemiol Infect. 2019;147:e84. doi:10.1017/S095026881800345X30869000
  • Center for Infectious Disease Research and Policy. Camel with MERS-CoV had signs of illness. Available from: http://www.cidrap.umn.edu/news-perspective/2013/11/camel-mers-cov-had-signs-illness. Accessed 1112, 2013.
  • Shirato K, Melaku SK, Kawachi K, et al. Middle East respiratory syndrome coronavirus in dromedaries in Ethiopia is antigenically different from the Middle East isolate EMC. Front Microbiol. 2019;10:1326. doi:10.3389/fmicb.2019.0132631275264
  • Donnelly CA, Malik MR, Elkholy A, Cauchemez S, Van Kerkhove MD. Worldwide reduction in MERS cases and deaths since 2016. Emerg Infect Dis. 2019;25(9):1758–1760. doi:10.3201/eid2509.19014331264567
  • Gaffar BO, El Tantawi M, Al-Ansari AA, AlAgl AS, Farooqi FA, Almas KM. Knowledge and practices of dentists regarding MERS-CoV. A cross-sectional survey in Saudi Arabia. Saudi Med J. 2019;40(7):714–720. doi:10.15537/smj.2019.7.2430431287133
  • Hemida MG, Alnaeem A. Some one health based control strategies for the Middle East respiratory syndrome coronavirus. One Health. 2019;8:100102. doi:10.1016/j.onehlt.2019.10010231485476
  • Al-Ahmadi K, Alahmadi S, Al-Zahrani A. Spatiotemporal clustering of Middle East respiratory syndrome coronavirus (MERS-CoV) incidence in Saudi Arabia, 2012–2019. Int J Environ Res Public Health. 2019;16(14):2520. doi:10.3390/ijerph16142520
  • Nour M, Alhajri M, Farag EABA, et al. How do the first days count? A case study of Qatar experience in emergency risk communication during the MERS-CoV outbreak. Int J Environ Res Public Health. 2017;14(12):1597. doi:10.3390/ijerph14121597
  • Behzadi MA, Leyva-Grado VH. Overview of current therapeutics and novel candidates against influenza, respiratory syncytial virus, and Middle East respiratory syndrome coronavirus infections. Front Microbiol. 2019;10:1327. doi:10.3389/fmicb.2019.0132731275265
  • Lee SY, Khang YH, Lim HK. Impact of the 2015 Middle East respiratory syndrome outbreak on emergency care utilization and mortality in South Korea. Yonsei Med J. 2019;60(8):796–803. doi:10.3349/ymj.2019.60.8.79631347336
  • Middle East respiratory syndrome coronavirus; Guidelines for healthcare professionals. Available from: https://www.moh.gov.sa/CCC/healthp/regulations/Documents/MERS-CoV%20Guidelines%20for%20Healthcare%20Professionals%20-%20May%202018%20-%20v5.1%20%281%29.pdf.
  • Rahman A, Sarkar A. Risk factors for fatal Middle East respiratory syndrome coronavirus infections in Saudi Arabia: analysis of the WHO line list, 2013–2018. Am J Public Health. 2019;109(9):1288–1293. doi:10.2105/AJPH.2019.30518631318592
  • Zumla A, Memish ZA, Hui DS, Perlman S. Vaccine against Middle East respiratory syndrome coronavirus. Lancet Infect Dis. 2019;19(10):1054–1055. doi:10.1016/S1473-3099(19)30477-331559955
  • Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A. The Middle East respiratory syndrome (MERS). Infect Dis Clin North Am. 2019;33(4):891–905. doi:10.1016/j.idc.2019.08.00131668197
  • Choi WS, Kang C-I, Kim Y, et al. Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea. Infect Chemother. 2016;48(2):118–126. doi:10.3947/ic.2016.48.2.11827433382
  • Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301–306. doi:10.1016/j.ijid.2014.09.00325303830
  • World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-48.. [updated 38, 2020]. Availabe from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn.16f7ccef_4.
  • Haverkamp A-K, Bosch BJ, Spitzbarth I, et al. Detection of MERS-CoV antigen on formalin-fixed paraffin-embedded nasal tissue of alpacas by immunohistochemistry using human monoclonal antibodies directed against different epitopes of the spike protein. Vet Immunol Immunopathol. 2019;218:109939. doi:10.1016/j.vetimm.2019.10993931526954
  • Kim H, Park M, Hwang J, et al. Correction to Development of label-free colorimetric assay for MERS-CoV using gold nanoparticles. ACS Sens. 2019;4(9):2554. doi:10.1021/acssensors.9b0145031483133
  • Alenazi TH, Arabi YM. Severe Middle East respiratory syndrome (MERS) pneumonia. Ref Module Biomed Sci. 2019;B978-0-12-801238-3.11488–6.
  • Okba NMA, Raj VS, Widjaja I, et al. Sensitive and specific detection of low-level antibody responses in mild Middle East respiratory syndrome coronavirus infections. Emerg Infect Dis. 2019;25(10):1868–1877. doi:10.3201/eid2510.19005131423970
  • Modjarrad K, Roberts CC, Mills KT, et al. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a Phase 1, open-label, single-arm, dose-escalation trial. Lancet Infect Dis. 2019;19(9):1013–1022. doi:10.1016/S1473-3099(19)30266-X31351922
  • Zhou H, Chen Y, Zhang S, et al. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein. Nat Commun. 2019;10(1):3068. doi:10.1038/s41467-019-10897-431296843
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-732007143
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585